|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-3-7
|
|
pubmed:abstractText |
Social anxiety disorder (SAD) is common and debilitating. Although exposure therapy is one of the most effective forms of psychotherapy for this disorder, many patients remain symptomatic. Fear reduction in exposure therapy is similar to extinction learning, and early clinical data with specific phobias suggest that the treatment effects of exposure therapy for SAD may be enhanced with d-cycloserine, an agonist at the glutamatergic N-methyl-d-aspartate receptor.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0003-990X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
298-304
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16520435-Adult,
pubmed-meshheading:16520435-Combined Modality Therapy,
pubmed-meshheading:16520435-Cycloserine,
pubmed-meshheading:16520435-Double-Blind Method,
pubmed-meshheading:16520435-Drug Administration Schedule,
pubmed-meshheading:16520435-Fear,
pubmed-meshheading:16520435-Female,
pubmed-meshheading:16520435-Humans,
pubmed-meshheading:16520435-Implosive Therapy,
pubmed-meshheading:16520435-Male,
pubmed-meshheading:16520435-Phobic Disorders,
pubmed-meshheading:16520435-Placebos,
pubmed-meshheading:16520435-Psychotherapy, Group,
pubmed-meshheading:16520435-Receptors, N-Methyl-D-Aspartate,
pubmed-meshheading:16520435-Speech
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
|
|
pubmed:affiliation |
Department of Psychology and Center for Anxiety and Related Disorders, Boston University, Boston, MA 02215, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
